Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition.

BACKGROUND Because prior studies have established the critical role of the endothelium in preventing vascular thrombosis and intimal thickening, we designed a series of experiments to determine the feasibility of percutaneous local catheter delivery of recombinant protein to accelerate development of an intact endothelial monolayer after stent implantation. METHODS AND RESULTS Balloon injury followed by percutaneous delivery of a 15-mm-long, balloon-expandable metallic stent was performed in 64 rabbit external iliac arteries (baseline diameter, 2.67 +/- 0.07 mm). Planimetric time-course analysis disclosed < 20% stent endothelialization at 4 days, < 40% at 7 days, and near-complete endothelialization at 28 days. The reporter protein horseradish peroxidase and the endothelial cell-specific recombinant protein vascular endothelial growth factor (VEGF) were each effectively delivered from a local delivery catheter (channel balloon catheter, ChB) after stent implantation. Although local catheter delivery (of vehicle control) itself mildly retarded the extent of stent endothelialization (10.6 +/- 2.9%) versus no local delivery (25.5 +/- 6.6%, P = .045), local ChB delivery of 100 micrograms VEGF overcame this catheter effect: By day 7, stent endothelialization was nearly complete (91.8 +/- 3.8%) (P < .0001 versus no local delivery). Consequently, stent thrombus was reduced in the VEGF-treated group (mural thrombus, 5.3 +/- 3.7%) versus no local delivery (29.3 +/- 6.8%, P = .006). Occlusive thrombus was seen only in the absence of local VEGF administration. CONCLUSIONS (1) Local delivery of recombinant protein to the arterial wall is feasible after stent implantation, and (2) local delivery of the endothelial cell mitogen VEGF accelerates stent endothelialization, reducing stent thrombosis. These results thus establish a novel means by which the safety and/or bioactivity of endovascular stents may be further enhanced.

[1]  C. Bauters,et al.  Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. , 1996, Circulation.

[2]  P. Libby,et al.  Implantation of vascular grafts lined with genetically modified endothelial cells. , 1989, Science.

[3]  N. Flavahan,et al.  Natural Course of the Impairment of Endothelium-Dependent Relaxations After Balloon Endothelium Removal in Porcine Coronary Arteries Possible Dysfunction of a Pertussis Toxin-Sensitive G Protein , 1989, Circulation research.

[4]  K. Robinson,et al.  Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. , 1992, Journal of the American College of Cardiology.

[5]  M. Perricaudet,et al.  Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. , 1995, The Journal of clinical investigation.

[6]  E J Topol,et al.  Local drug delivery for the prevention of restenosis. Fact, fancy, and future. , 1994, Circulation.

[7]  R. Virmani,et al.  Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo. , 1996, Circulation.

[8]  R. Virmani,et al.  Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. , 1992, Circulation research.

[9]  J. Glover,et al.  Endothelial seeding of polytetrafluoroethylene popliteal bypasses. A preliminary report. , 1987, Journal of vascular surgery.

[10]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[11]  M. Leon,et al.  935-32 Differing Mechanisms of Late Arterial Responses to Transcatheter Therapy: A Serial Quantitative Angiographic and Intravascular Ultrasound Study , 1995 .

[12]  W. J. Visser,et al.  Endothelialization of Intravascular Stents , 1988 .

[13]  A. Gown,et al.  Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. , 1985, The American journal of pathology.

[14]  W. Baxley,et al.  Vascular pathology of balloon-expandable flexible coil stents in humans. , 1992, Journal of the American College of Cardiology.

[15]  J. Isner.  Vascular remodeling. Honey, I think I shrunk the artery. , 1994, Circulation.

[16]  J. Isner,et al.  Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. , 1995, Circulation.

[17]  J. Isner,et al.  Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. , 1995, Journal of vascular surgery.

[18]  B. Keyt,et al.  The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[19]  P. Kadowitz,et al.  Angiopeptin enhances acetylcholine-induced relaxation and inhibits intimal hyperplasia after vascular injury. , 1993, The American journal of physiology.

[20]  Julio C. Palmaz,et al.  Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study , 1991, Circulation.

[21]  W. Kübler,et al.  Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. , 1995, Circulation.

[22]  B. Goldman,et al.  Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase. A new catheter approach. , 1987, Atherosclerosis.

[23]  J. Isner,et al.  Prospects for site-specific delivery of pharmacologic and molecular therapies. , 1994, Journal of the American College of Cardiology.

[24]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[25]  J. Isner,et al.  Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. , 1995, Circulation.

[26]  J. Palmaz,et al.  Atherosclerotic rabbit aortas: expandable intraluminal grafting. , 1986, Radiology.

[27]  T. Lüscher,et al.  Endothelial dysfunction in coronary artery disease. , 1993, Annual review of medicine.

[28]  J. Isner,et al.  Accelerated re-endothelialization and reduced neointimal thickening following catheter transfer of phVEGF165 , 1996 .

[29]  K. Robinson,et al.  Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. , 1987, Circulation.

[30]  R. Virmani,et al.  Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery , 1993, Coronary artery disease.

[31]  K. Robinson,et al.  Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. , 1995, Circulation.

[32]  P D Verdouw,et al.  Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. , 1996, Circulation.

[33]  W Rutsch,et al.  Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. , 1996, Circulation.

[34]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[35]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[36]  B Meier,et al.  Angiographic follow-up after placement of a self-expanding coronary-artery stent. , 1991, The New England journal of medicine.

[37]  R. Kuntz,et al.  The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. , 1994, Circulation.

[38]  T. Bjornsson,et al.  Acidic fibroblast growth factor promotes vascular repair. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. LeFree,et al.  Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. , 1987, Circulation.

[40]  E. Edelman,et al.  Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. , 1993, Circulation.

[41]  R. Virmani,et al.  Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent. , 1996, Circulation.

[42]  J. Bagu,et al.  Comparison of hexamethyldisilazane (HMDS), Peldri II, and critical‐point drying methods for scanning electron microscopy of biological specimens , 1993, Microscopy research and technique.

[43]  N K Hollenberg,et al.  Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. , 1990, Circulation.

[44]  P Hall,et al.  Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. , 1995, Circulation.

[45]  P. Serruys,et al.  Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. , 1993, Journal of the American College of Cardiology.

[46]  D. Dichek,et al.  Seeding of intravascular stents with genetically engineered endothelial cells. , 1989, Circulation.

[47]  J F Cornhill,et al.  Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. , 1995, Circulation research.

[48]  S. Liu,et al.  Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. , 1993, The American journal of physiology.

[49]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[50]  E. Edelman,et al.  Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. , 1994, The American journal of physiology.

[51]  C. Bauters,et al.  NO synthesis is involved in structural and functional effects of ACE inhibitors in injured arteries. , 1996, The American journal of physiology.

[52]  M. Reidy,et al.  Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. , 1990, The Journal of clinical investigation.

[53]  D. W. Vinter,et al.  Enhanced patency of small-diameter, externally supported Dacron iliofemoral grafts seeded with endothelial cells. , 1982, Surgery.

[54]  R A Schatz,et al.  Balloon-expandable intracoronary stents in the adult dog. , 1987, Circulation.